adamantane has been researched along with Colonic Neoplasms in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Eichmann, TO; Grbčić, P; Kraljević Pavelić, S; Sedić, M | 1 |
Aziz, N; Jung, J; Kissil, JL; Puré, E; Santos, AM | 1 |
Chung, KS; Jin, Y; Kang, JE; Kang, MR; Kim, HM; Lee, JJ; Lee, K; Lee, MK; Park, SK; Song, KB; Won, M; Yang, EG | 1 |
Chumanevich, AA; Cui, X; Davis, T; Hofseth, LJ; Poudyal, D; Smith, CD; Wood, PA | 1 |
Chang, YF; Chern, YT; Chi, CW; Hsu, YC; Huang, ML; Hung, HF; Lee, HJ; Wang, JJ | 1 |
Chang, YF; Chern, YT; Chi, CW; Wang, JJ | 1 |
Chen, YC; Chern, YT; Chi, CW; Huang, KT; Wang, JJ | 1 |
Chen, YC; Chern, YT; Chi, CW; Lee, JY; Wang, JJ | 1 |
Alemany, C; Camici, M; Ciudad, CJ; Cos, J; Noe, V; Tozzi, MG; Turchi, G; Turriani, M | 1 |
Chang, YF; Chern, YT; Chi, CW; Liu, TY; Wang, JJ | 1 |
10 other study(ies) available for adamantane and Colonic Neoplasms
Article | Year |
---|---|
The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.
Topics: Adamantane; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Nuclear Proteins; Nucleophosmin; Phosphotransferases (Alcohol Group Acceptor); Proto-Oncogene Proteins c-akt; Pyridines; Tumor Cells, Cultured; Tumor Protein, Translationally-Controlled 1; Vemurafenib | 2021 |
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.
Topics: Adamantane; Animals; Cell Line, Tumor; Cell Proliferation; Collagen; Colonic Neoplasms; Endopeptidases; Female; Gelatinases; Genes, ras; Lung Neoplasms; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mice, Transgenic; Neoplasm Transplantation; Protease Inhibitors; Pyrrolidines; Serine Endopeptidases; Stromal Cells; Transplantation, Isogeneic | 2009 |
LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line.
Topics: Acetanilides; Adamantane; Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Cell Line; Colonic Neoplasms; Female; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Oxygen; Procollagen-Proline Dioxygenase; Proteasome Endopeptidase Complex; Proteins; Up-Regulation; von Hippel-Lindau Disease | 2010 |
Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.
Topics: Adamantane; Animals; Azoxymethane; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Extracellular Signal-Regulated MAP Kinases; Lysophospholipids; Mice; Mice, Inbred C57BL; Phosphotransferases (Alcohol Group Acceptor); Proto-Oncogene Proteins c-akt; Pyridines; Sphingosine | 2010 |
Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.
Topics: Adamantane; Animals; Antineoplastic Agents; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; HCT116 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Tumor Suppressor Protein p53 | 2012 |
Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a novel cytostatic and differentiation inducing agent, on human colon cancer cells.
Topics: Adamantane; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Male; Mice; Mice, Inbred BALB C; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
In vitro and in vivo growth inhibition and G1 arrest in human cancer cell lines by diaminophenyladamantane derivatives.
Topics: Adamantane; Animals; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Drug Screening Assays, Antitumor; G1 Phase; Humans; Inhibitory Concentration 50; Male; Mice; Mice, Inbred ICR; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Structure-Activity Relationship | 2004 |
The antitumor effect of a novel differentiation inducer, 2, 2-Bis (4-(4-amino-3-hydroxyphenoxy) phenyl) adamantane (DPA), in combinatory therapy on human colon cancer.
Topics: Adamantane; Animals; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Blotting, Western; Cadherins; Camptothecin; Carcinoembryonic Antigen; Catenins; Cell Adhesion Molecules; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Delta Catenin; Dose-Response Relationship, Drug; Drug Synergism; Fibronectins; G1 Phase; HT29 Cells; Humans; Intracellular Signaling Peptides and Proteins; Irinotecan; Male; Mice; Mice, Inbred ICR; Mice, Nude; Phosphoproteins; Resting Phase, Cell Cycle; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2006 |
Cytotoxicity of deoxycoformycin on human colon carcinoma cell lines.
Topics: 5'-Nucleotidase; Adamantane; Adenosine Deaminase; Adenosine Kinase; Adenosine Monophosphate; AMP Deaminase; Animals; Cell Line; Cell Survival; CHO Cells; Colonic Neoplasms; Cricetinae; Deoxyadenosines; Dipyridamole; Humans; Kinetics; Pentostatin; Tumor Cells, Cultured | 1994 |
Dimethyladamantylmaleimide-induced in vitro and in vivo growth inhibition of human colon cancer Colo205 cells.
Topics: Adamantane; Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Caspases; Cell Division; Colonic Neoplasms; Cytochrome c Group; Dose-Response Relationship, Drug; Flow Cytometry; Free Radicals; G2 Phase; Humans; Maleimides; Membrane Potentials; Mice; Mice, SCID; Mitochondria; Mitosis; Necrosis; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |